These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Heterogeneity of endothelium-dependent and endothelium-independent responses to aggregating platelets in porcine pulmonary arteries. Zellers TM, Shimokawa H, Yunginger J, Vanhoutte PM. Circ Res; 1991 May; 68(5):1437-45. PubMed ID: 2019001 [Abstract] [Full Text] [Related]
44. Effects of tryptamine mediated through 2 states of the 5-HT2 receptor in calf coronary artery. Frenken M, Kaumann AJ. Naunyn Schmiedebergs Arch Pharmacol; 1988 May; 337(5):484-92. PubMed ID: 3137478 [Abstract] [Full Text] [Related]
52. Adenine nucleotides, serotonin, and endothelium-dependent relaxations to platelets. Houston DS, Shepherd JT, Vanhoutte PM. Am J Physiol; 1985 Mar; 248(3 Pt 2):H389-95. PubMed ID: 3156512 [Abstract] [Full Text] [Related]
53. Interaction between 5-hydroxytryptamine and other vasoconstrictor substances in the isolated femoral artery of the rabbit; effect of ketanserin (R 41 468). Van Nueten JM, Janssen PA, De Ridder A, Vanhoutte PM. Eur J Pharmacol; 1982 Feb 05; 77(4):281-7. PubMed ID: 7060640 [Abstract] [Full Text] [Related]
54. The effects of platelet-derived contractile agents on human digital arteries. Moulds RF, Iwanov V, Medcalf RL. Clin Sci (Lond); 1984 Apr 05; 66(4):443-51. PubMed ID: 6697664 [Abstract] [Full Text] [Related]
55. Inhibition of thromboxane A2-induced vasocontraction by KF4939, a new anti-platelet agent, in rabbit mesenteric and dog coronary arteries. Yamada K, Kubo K, Shuto K, Nakamizo N. Jpn J Pharmacol; 1984 Nov 05; 36(3):283-90. PubMed ID: 6521073 [Abstract] [Full Text] [Related]
56. Role of internalization in platelet activation induced by collagen fibers--differential effects of aspirin, cytochalasin D, and prostaglandin E1. Ruf A, Patscheke H, Morgenstern E. Thromb Haemost; 1991 Dec 02; 66(6):708-14. PubMed ID: 1796416 [Abstract] [Full Text] [Related]
57. EPA:DHA 6:1 is a superior omega-3 PUFAs formulation attenuating platelets-induced contractile responses in porcine coronary and human internal mammary artery by targeting the serotonin pathway via an increased endothelial formation of nitric oxide. Zgheel F, Perrier S, Remila L, Houngue U, Mazzucotelli JP, Morel O, Auger C, Schini-Kerth VB. Eur J Pharmacol; 2019 Jun 15; 853():41-48. PubMed ID: 30878386 [Abstract] [Full Text] [Related]